ArticleBritish journal of clinical pharmacology2022

Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open-label, single-dose, parallel-group study.

Xinhui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.